Verona Pharma
London
About Verona Pharma
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, such as asthma, allergic rhinitis (hay fever), chronic obstructive pulmonary disease (COPD) and cough. The company creates therapies to address unmet medical requirements in the treatment of respiratory disorders. Verona Pharma was established in 2005 by Clive Page in London, England.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $1.3B
- Funding stage: M&A
- Last round: Post-IPO Debt (May 2024)
- Ticker: lse:VRP
- Website: veronapharma.com
- Phone: +44 20 7863 3300
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/verona-pharma-129679 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.